Beta-adrenergic blocking drugs

There are currently six beta-adrenoceptor blocking drugs on the market. Although all the drugs competitively interact with the beta-adrenergic receptors, their pharmacokinetics and ancillary properties distinguish them from one another. By understanding these differences, the various beta-adrenocept...

Full description

Saved in:
Bibliographic Details
Published inAnnual review of medicine Vol. 36; p. 145
Main Authors Gerber, J G, Nies, A S
Format Journal Article
LanguageEnglish
Published United States 01.01.1985
Subjects
Adrenergic beta-Antagonists - adverse effects
Adrenergic beta-Antagonists - pharmacology
Adrenergic beta-Antagonists - therapeutic use
Angina Pectoris - drug therapy
Arrhythmias, Cardiac - drug therapy
Chemical Phenomena
Chemistry
Heart - drug effects
Heart Block - chemically induced
Heart Failure - chemically induced
Humans
Hypertension - drug therapy
Ion Channels - drug effects
Kinetics
Lipids
Myocardial Infarction - prevention & control
Raynaud Disease - chemically induced
Sodium - metabolism
Substance Withdrawal Syndrome
Online AccessGet more information

Cover

More Information
Summary:There are currently six beta-adrenoceptor blocking drugs on the market. Although all the drugs competitively interact with the beta-adrenergic receptors, their pharmacokinetics and ancillary properties distinguish them from one another. By understanding these differences, the various beta-adrenoceptor drugs can be rationally used to a therapeutic advantage.
ISSN:0066-4219
1545-326X
DOI:10.1146/annurev.me.36.020185.001045